BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 128.81% | -55.50% | -46.59% | 27.75% | 21.70% |
| Total Depreciation and Amortization | -239.46% | 0.24% | 136.71% | 53.78% | 39.75% |
| Total Amortization of Deferred Charges | 0.49% | 2.67% | -27.99% | -25.50% | 1.78% |
| Total Other Non-Cash Items | -137.84% | 2,530.79% | -85.08% | -5.79% | -55.34% |
| Change in Net Operating Assets | -1,579.93% | -106.76% | 354.32% | -193.10% | 76.87% |
| Cash from Operations | -33.62% | -401.50% | 81.66% | -178.96% | 30.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 115.79% | -55.73% | -66.10% | 87.59% | -5.88% |
| Total Debt Repaid | -133,700.00% | -25.00% | 94.59% | -208.33% | 74.47% |
| Issuance of Common Stock | 62.53% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.69% | 278.29% | -65.77% | 86.72% | -4.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.36% | 100.46% | 237.25% | -172.70% | 1,159.04% |